Resting state networks in major depressive disorder
Arpan Dutta1, Shane McKie1, J F William Deakin1
1Neuroscience & Psychiatry Unit, Institute of Brain, Behaviour and Mental Health, Stopford Building, University of Manchester, Manchester, M13 9PT, UK.
Psychiatry Research
|December 3, 2014
Summary
Resting state functional magnetic resonance imaging (fMRI) reveals brain networks in major depressive disorder (MDD). This review explores resting-state network abnormalities and proposes a novel drug development approach for MDD.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Resting state functional magnetic resonance imaging (fMRI) investigates spontaneous brain activity to identify neural networks.
- Major depressive disorder (MDD) research often focuses on the default mode network (DMN), but other networks are also implicated.
- Abnormalities in resting-state networks are observed in MDD across various brain regions.
Purpose of the Study:
- To review the literature on resting-state networks in MDD.
- To discuss potential confounds like medication effects.
- To present a novel approach for analyzing antidepressant effects and identifying efficacy signatures for drug development.
Main Methods:
- Review of existing literature on resting-state fMRI in MDD.
- Identification of commonly reported brain regions with abnormalities.
- Proposal of a new analytical framework for drug efficacy.
Main Results:
- MDD is associated with state- and trait-dependent abnormalities in multiple brain networks, including the DMN, salience, and cognitive control networks.
- Specific regions like the cerebellum, ACC, dlPFC, and amygdala show alterations.
- Medication effects represent a significant confound in current research.
Conclusions:
- Resting-state fMRI is a valuable tool for understanding MDD pathophysiology.
- Further research is needed to clarify the impact of medication on resting-state networks.
- The proposed novel approach may aid in the development of more effective antidepressant treatments.
Keywords:
Default mode networkFunctional magnetic resonance imagingMajor depressive disorderResting stateSalience networkMore Related Videos
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Depressive Disorders: Etiology
887
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
887
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Long-term Depression
33.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.9K
Long-term Depression
3.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.7K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K


